GCTK Fundamental Analysis - GLUCOTRACK INC

Fundamental Rating

Overall GCTK gets a fundamental rating of 1 out of 10. We evaluated GCTK against 188 industry peers in the Health Care Equipment & Supplies industry. While GCTK seems to be doing ok healthwise, there are quite some concerns on its profitability. GCTK does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

GCTK had negative earnings in the past year.

GCTK had a negative operating cash flow in the past year.

In the past 5 years GCTK always reported negative net income.

In the past 5 years GCTK always reported negative operating cash flow.

1.2 Ratios

GCTK has a Return On Assets of -275.73%. This is amonst the worse of the industry: GCTK underperforms 95.74% of its industry peers.

GCTK has a Return On Equity of -365.16%. This is amonst the worse of the industry: GCTK underperforms 85.11% of its industry peers.

		Industry Rank	Sector Rank
ROA	-275.73%
ROE	-365.16%
ROIC	N/A

ROA(3y)-130.51%

ROA(5y)-147.55%

ROE(3y)-220.48%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for GCTK so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The number of shares outstanding for GCTK has been increased compared to 1 year ago.

The number of shares outstanding for GCTK has been increased compared to 5 years ago.

GCTK has a better debt/assets ratio than last year.

2.2 Solvency

GCTK has an Altman-Z score of -23.55. This is a bad value and indicates that GCTK is not financially healthy and even has some risk of bankruptcy.

With a Altman-Z score value of -23.55, GCTK is not doing good in the industry: 91.49% of the companies in the same industry are doing better.

A Debt/Equity ratio of 0.03 indicates that GCTK is not too dependend on debt financing.

GCTK has a better Debt to Equity ratio (0.03) than 64.89% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.03
Debt/FCF	N/A
Altman-Z	-23.55

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

GCTK has a Current Ratio of 4.85. This indicates that GCTK is financially healthy and has no problem in meeting its short term obligations.

GCTK's Current ratio of 4.85 is fine compared to the rest of the industry. GCTK outperforms 72.34% of its industry peers.

GCTK has a Quick Ratio of 4.85. This indicates that GCTK is financially healthy and has no problem in meeting its short term obligations.

GCTK has a better Quick ratio (4.85) than 78.72% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	4.85
Quick Ratio	4.85

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

GCTK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -46.63%.

EPS 1Y (TTM)-46.63%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%94.26%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

GCTK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

GCTK does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

GLUCOTRACK INC

NASDAQ:GCTK (6/10/2025, 8:00:01 PM)

After market: 0.1595 +0 (+1.59%)

0.157

+0.01 (+3.97%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners0.43%

Inst Owner Change54.86%

Ins Owners0.16%

Ins Owner Change0.26%

Market Cap4.02M

AnalystsN/A

Price TargetN/A

Short Float %5.68%

Short Ratio0.21

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	N/A
P/FCF	N/A
P/OCF	N/A
P/B	0.55
P/tB	0.55
EV/EBITDA	N/A

EPS(TTM)-54.77

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-0.49

FCFYN/A

OCF(TTM)-0.49

OCFYN/A

SpS0

BVpS0.28

TBVpS0.28

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-275.73%
ROE	-365.16%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-130.51%

ROA(5y)-147.55%

ROE(3y)-220.48%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score6

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0.03
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	135%
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	4.85
Quick Ratio	4.85
Altman-Z	-23.55

F-Score6

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)5.42%

Cap/Depr(5y)35.05%

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-46.63%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%94.26%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-72.09%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-205.43%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-204.49%

OCF growth 3YN/A

OCF growth 5YN/A

GLUCOTRACK INC (GCTK) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens